New potentiometric sensors based on selective recognition sites for determination of ephedrine in some pharmaceuticals and biological fluids.
New cost-effective potentiometric membrane sensors with cylindrical configuration responsive to ephedrine are described. The sensors setup is, based on the use of triacetyl-β-cyclodextrin [(triacetyl-β-CD)] as a neutral ionophore embedded in a plasticized poly (vinyl chloride) (PVC) matrix (sensor I) and carboxylated poly(vinyl chloride) [(PVC-COOH)] as a simultaneous plastic matrix and ion exchanger (sensor II). Both sensors showed significant enhancement of response towards ephedrinium cation (EPD(+)) over a concentration range of 3.0 × 10(-5)-8.0 × 10(-3) mol L(-1) at pH 4-9 and 3-8 with low detection limits of 5.7 × 10(-6) and 6.2 × 10(-6) mol L(-1) for sensors (I) and (II), respectively. The sensors displayed near-Nernstian cationic slope of 57.0 and 55.6 mV decade(-1) for EPD(+) and the effects of lipophilic salts and various foreign common ions were examined. The sensors were also satisfactorily used as tubular detectors in a double channel flow injection system. The intrinsic characteristics of the detectors in a low dispersion manifold under hydrodynamic mode of operation were determined and compared with data obtained under batch mode of operation. Validation of the method revealed good performance characteristics including long life span, good selectivity for EPD(+) over a wide variety of other organic compounds, long term stability, high reproducibility, fast response, low detection limit, wide measurement range, acceptable accuracy and precision. Applications of the sensors to the determination of EPD(+) in pharmaceutical formulations and spiked biological fluid samples were carried out and compared with standard techniques. Notably, the sensors introduced offer several advantages over many of those previously described that are amenable to quality control/quality assurance assessment of the homogeneity, stability and purity of ephedrine drug tablets.